Critical Keynote Discussions Lead Pharma CI + MR Asia Conference & Exhibition in Tokyo

TOKYO, Japan - Oct. 17, 2018 - PRLog -- A full lineup of innovative keynote sessions will set the stage for two days of industry discussions at the 2018 Pharma CI + MR Asia Conference & Exhibition, held 29-30 November at the Westin Tokyo in Tokyo, Japan.

Here's a sampling of the keynotes:

·         Value Based Healthcare

·         Drivers for Improving Japanese Healthcare

·         Challenges and Opportunities for Pharma and Biotech

·         And more!

Pharma CI + MR Asia is the first event of its kind to focus on the unique intelligence and research issues facing Asia, and how those issues relate worldwide. This forum presents a complete look at why market research is vital to competitive intelligence and why you should integrate both into your company's strategy.

Agenda topics include:

·         HCP's Social Media Tracking

·         Role of R&D in Partnering and Strategy

·         Building a Community of Insights

·         And more!

View the detailed agenda here: http://pharmaciconference.com/

Register by Friday 31 October to take advantage of the Early Rates and secure the best possible price.

The Pharma CI + MR Asia Conference & Exhibition features the participation of the world's top companies, including: Abbott Laboratories, Alnylam, Biogen, Bristol Myers Squibb, Celgene, Daiichi Sankyo, Eisai, Lifescience Dynamics, Merck, Pfizer, Seed Planning Inc., Shionogi, Takeda, Vetter Pharma, and more.

The Pharma CI + MR Asia Conference & Exhibition is The Best and Largest Assembly of Competitive Intelligence AND Market Research Executives in Pharma, Biotech, and Medical Devices in the World for 10+ Years.

To register to attend the conference, go to: http://pharmaciconference.com/

For more information, call +1-212-228-7974 or email info@pharmaciconference.com